Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients—Design and baseline data ‘LIBERATE’ trial
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference39 articles.
1. ATAC Trialists’ Group. Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years’ adjuvant treatment for breast cancer;Howell;Lancet,2005
2. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer;Thürlimann;N Engl J Med,2005
3. Risk of menopause during the first year after breast cancer diagnosis;Goodwin;J Clin Oncol,1999
4. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer;Bines;J Clin Oncol,1996
5. Management of menopausal symptoms in patients with breast cancer: an evidence-based approach;Hickey;Lancet Oncol,2005
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Breast Cancer Risk – Genes, Environment and Clinics;Geburtshilfe und Frauenheilkunde;2011-12
2. Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients—Data from LIBERATE trial;Maturitas;2011-12
3. Botulinum Toxin for the Treatment of Menopausal Hot Flushes;Dermatologic Surgery;2011-11
4. Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials;Gynecological Endocrinology;2010-06-29
5. Recent advances on the action of estrogens and progestogens in normal and pathological human endometrium;Hormone Molecular Biology and Clinical Investigation;2010-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3